|
Organisation | |
Clinique | |
Diagnostic | |
Research | |
Formation |
| Home < Research < Publications |
   |
|
||
|
||
|
Archives 2002-2007 |
||
|
||
|
2008 | 2009 | 2010 | 2011 | 2012
Publications : 2012  |
||
| 1: | Bioley G., Bussat P., Lassus A., Schneider M., Terrettaz J. and Corthésy B. | |
| The phagocytosis of gas-filled microbubbles by human and murine antigen-presenting cells.
Biomaterials 2012, 33:333-342. |
||
Publications : 2011 |
||
| 1: | Bart P.-A. | |
| Allergy-immunology. Do we have to be afraid of biological agents ?
Rev. Med. Suisse 2011, 7:106-107. |
||
| 2: | Blüggel M., Spertini F., Lutter P., Wassenberg J., Audran R., Corthésy B., Müllner S., Blum S., Wattenberg A., Mercenier A., Affolter M. and Kussmann M. | |
| Toward protein biomarkers for allergy: CD4+ T cell proteomics in allergic and nonallergic subjects sampled in and out of pollen season.
J. Proteome. Res. 2011, 10:1558-1570. |
||
| 3: | Cellerai C., Harari A., Stauss H., Yerly S., Geretti A.-M., Carroll A., Yee T., Ainsworth J., Williams I., Sweeney J., Freedman A., Johnson M., Pantaleo G. and Kinloch-de Loes S. | |
| Early and prolonged antiretroviral therapy is associated with an HIV-1-specific T-cell profile comparable to that of long-term non-progressors.
PLoS One 2011, 6:e18164. |
||
| 4: | Comte D., Petitpierre S., Bart P.-A., Leimgruber A. and Spertini F. | |
| Hymenoptera venom allergy: new diagnostic tools and management.
Rev. Med. Suisse 2011, 7: 844-849. |
||
| 5: | Corey L., Nabel G.J., Dieffenbach C., Gilbert P., Haynes B.F., Johnston M., Kublin J., Lane H.C., Pantaleo G., Picker L.J. and Fauci A.S. | |
| HIV-1 vaccines and adaptive trial designs.
Sci. Transl. Med. 2011, 3:79ps13. |
||
| 6: | De Crignis E., Guglietta S., Foley B.T., Negroni M., Di Narzo A.F., Waelti Da Costa V., Cavassini M., Bart P.-A., Pantaleo G. and Graziosi C. | |
| Nonrandom distribution of cryptic repeating triplets of purines and pyrimidines (RNY)n in gp120 of HIV type1.
AIDS Res. Hum. Retrov. In press. |
||
| 7: | Fehr J., Glass T.R., Louvel S., Hamy F., Hirsch H.H., von Wyl V., Böni J., Yerly S., Bürgisser P., Cavassini M., Fux C.A., Hirschel B., Vernazza P., Martinetti G., Bernasconi E., Günthard H.F., Battegay M., Bucher H.C., Klimkait T. and the Swiss HIV Cohort Study. | |
| Replicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals--the Swiss HIV Cohort Study.
J. Transl. Med. 2011, 9:14. |
||
| 8: | Flynn B.J., Kastenmüller K., Wille-Reece U., Tomaras G.D., Alam M., Lindsay R.W., Salazar A.M., Perdiguero B., Gomez C.E., Wagner R., Esteban M., Park C.G., Trumpfheller C., Keler T., Pantaleo G., Steinman R.M. and Seder R. | |
| Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates.
Proc. Natl. Acad. Sci. USA 2011, 108:7131-7136. |
||
| 9: | Forbes S.J., Bumpus T., McCarthy E.A., Corthésy B. and Mantis NJ. | |
| Transient suppression of Shigella flexneri type 3 secretion by a protective O-antigen-specific monoclonal IgA.
MBio. 2011, 2:e00042-11. |
||
| 10: | Gaillard J., Bart P.-A., Leimgruber A. and Spertini F. | |
| Allergen specific immunotherapy: review of new perspectives.
Rev. Med. Suisse 2011, 7:850-855. |
||
| 11: | García F., Bernaldo de Quirós J.C., Gómez C.E., Perdiguero B., Nájera J.L., Jiménez V., García-Arriaza J., Guardo A.C., Pérez I., Díaz-Brito V., Conde M.S., González N., Alvarez A., Alcamí J., Jiménez J.L., Pich J., Arnaiz J.A., Maleno M.J., León A., Muñoz-Fernández M.A., Liljeström P., Weber J., Pantaleo G., Gatell J.M., Plana M. and Esteban M. | |
| Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pol and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1-uninfected volunteers: A phase I clinical trial (RISVAC02).
Vaccine 2011, 29:8309-8316. |
||
| 12: | Giannoni E., Guignard L., Knaup Reymond M., Perreau M., Roth-Kleiner M., Calandra T. and Roger T. | |
| Estradiol and progesterone strongly inhibit the innate immune response of mononuclear cells in newborns.
Infect. Immun. 2011, 79:2690-2698. |
||
| 13: | Guarda G., Braun M., Staehli F., Tardivel A., Mattmann C., Förster I., Farlik M., Decker T., Du Pasquier R.A., Romero P. and Tschopp J. | |
| Type I interferon inhibits interleukin-1 production and inflammasome activation.
Immunity 2011, 34:213-223. |
||
| 14: | Hafner A.M., Corthésy B., Textor M. and Merkle HP. | |
| Tuning the immune response of dendritic cells to surface-assembled poly(I:C) on microspheres through synergistic interactions between phagocytic and TLR3 signaling.
Biomaterials 2011, 32:2651-2661. |
||
| 15: | Harari A., Rozot V., Bellutti Enders F., Perreau M., Mazza Stalder J., Nicod L.P., Cavassini M., Calandra T., Lazor Blanchet C., Jaton C., Faouzi M., Day C.L., Hanekom W.A., Bart P.-A. and Pantaleo G. | |
| Dominant TNF-α+ Mycobacterium tuberculosis–specific CD4+ T cell responses discriminate between latent infection and active disease.
Nat. Med. 2011, 17:372-376. |
||
| 16: | Kaufmann A., Kenfak-Foguena A., André C., Canellini G., Bürgisser P., Moradpour D., Darling K.E. and Cavassini M. | |
| Hepatitis E virus seroprevalence among blood donors in southwest Switzerland.
PLoS One 2011, 6:e21150. |
||
| 17: | Kenfak-Foguena A., Schöni-Affolter F., Bürgisser P., Witteck A., Darling K.E., Kovari H., Kaiser L., Evison J.M., Elzi L., Gurter-De La Fuente V., Jost J., Moradpour D., Abravanel F., Izpopet J., Cavassini M. and the Swiss HIV Cohort Study. | |
| Hepatitis E Virus seroprevalence and chronic infections in patients with HIV, Switzerland.
Emerg. Infect. Dis. 2011, 17:1074-1078. |
||
| 18: | Kuntzer T., Carota A., Novy J., Cavassini M. and Du Pasquier R.A. | |
| Rituximab is successful in an HIV-positive patient with MuSK myasthenia gravis.
Neurology 2011, 76:757-758. |
||
| 19: | Leimgruber A. | |
| Allergy-immunology. New therapies for acute attacks in hereditary angioedema.
Rev. Med. Suisse 2011, 7:103-105. |
||
| 20: | Leuppi J.D., Wildhaber J.H., Spertini F. and Helbling A. | |
| Intermittent or persistent rhinitis in children and adolescents with Asthma: «the Swiss LARA paediatrics survey».
Praxis (Bern 1994) 2011, 100:1225-1234. |
||
| 21: | Lysandropoulos A.P., Jaquiéry E., Jilek S., Pantaleo G., Schluep M. and Du Pasquier R.A. | |
| Vitamin D has a direct immunomodulatory effect on CD8+ T cells of patients with early multiple sclerosis and healthy control subjects.
J. Neuroimmunol. 2011, 233:240-244. |
||
| 22: | Mantis N.J., Rol N. and Corthésy B. | |
| Secretory IgA's complex roles in immunity and mucosal homeostasis in the gut.
Mucosal Immunol. 2011, 4:603-611. |
||
| 23: | Manuel O., Pascual M., Hoschler K., Giulieri S., Alves D., Ellefsen K., Bart P.-A., Venetz J.-P., Calandra T. and Cavassini M. | |
| Humoral response to the influenza A H1N1/09 monovalent AS03-adjuvanted vaccine in immunocompromised patients.
Clin. Infect. Dis. 2011, 52:248.256. |
||
| 24: | Mathias A. and Corthésy B. | |
| N-Glycans on secretory component: Mediators of the interaction between secretory IgA and gram-positive commensals sustaining intestinal homeostasis.
Gut Microbes 2011. In press. |
||
| 25: | Mathias A. and Corthésy B. | |
| Recognition of gram-positive intestinal bacteria by hybridoma- and colostrum-derived secretory immunoglobulin A is mediated by carbohydrates.
J. Biol. Chem. 2011, 286:17239-17247. |
||
| 26: | Miconnet I., Marrau A., Farina A., Taffé P., Vigano S., Harari A. and Pantaleo G. | |
| Large TCR diversity of virus-specific CD8 T cells provides the mechanistic basis for massive TCR renewal after antigen exposure.
J. Immunol. 2011, 186:7039-7049. |
||
| 27: | Olugbile S., Villard V., Bertholet S., Jafarshad A., Kulangara C., Roussilhon C., Frank G., Agak G.W., Felger I., Nebie I., Konate K., Kajava A.V., Schuck P., Druilhe P., Spertini F. and Corradin G. | |
| Malaria vaccine candidate: design of a multivalent subunit α-helical coiled coil poly-epitope.
Vaccine 2011, 29:7090-7099. |
||
| 28: | Paladini F., Cocco E., Potolicchio I., Fazekasova H., Lombardi G., Fiorillo M.T. and Sorrentino R. | |
| Divergent effect of cobalt and beryllium salts on the fate of peripheral blood monocytes and T lymphocytes.
Toxicol. Sci. 2011, 119:257-269. |
||
| 29: | Pellaton-Longaretti C., Boudousquié C., Barbier N., Barbey C., Argiroffo C.B., Donati Y., Sauty A. and Spertini F. | |
| CD4+CD25-mTGFbeta+ T cells induced by nasal application of ovalbumin transfer tolerance in a therapeutic model of asthma.
Int. Immunol. 2011, 23:17-27. |
||
| 30: | Perreau M., Welles H.C., Harari A., Hall O., Martin R., Maillard M., Dorta G., Bart P.-A., Kremer E.J., Tartaglia J., Wagner R., Esteban M., Levy Y. and Pantaleo G. | |
| DNA/NYVAC vaccine regimen induces HIV-specific CD4 and CD8 T-cell responses in intestinal mucosa.
J. Virol. 2011, 85:9854-9862. |
||
| 31: | Perrier C. and Corthésy B. | |
| Gut permeability and food allergies.
Clin. Exp. Allergy 2011, 41:20-28. |
||
| 32: | Quakkelaar E.D., Redeker A., Haddad E.K., Harari A., McCaughey S.M., Duhen T., Filali-Mouhim A., Goulet J.P., Loof N.M., Ossendorp F., Perdiguero B., Heinen P., Gomez C.E., Kibler K.V., Koelle D.M., Sékaly R.P., Sallusto F., Lanzavecchia A., Pantaleo G., Esteban M., Tartaglia J., Jacobs B.L. and Melief C.J. | |
| Improved innate and adaptive immunostimulation by genetically modified HIV-1 protein expressing NYVAC vectors.
PLoS One 2011, 6:e16819. |
||
| 33: | Riond P. | |
| L'implication du laboratoire dans la médecine des grands brûlés.
Labmed Suisse 2011, 38:167-171. |
||
| 34: | Roger T., Lugrin J., Le Roy D., Goy G., Mombelli M., Koessler T., Ding X.C., Chanson A.L., Reymond M.K., Miconnet I., Schrenzel J., François P. and Calandra T. | |
| Histone deacetylase inhibitors impair innate immune responses to Toll-like receptor agonists and to infection.
Blood 2011, 117:1205-1217. |
||
| 35: | Rozot V., Perreau M., Harari A. and Pantaleo G. | |
| Immunological signatures: a new tool to diagnose active tuberculosis disease ?
Med. Sci. (Paris) 2011, 27:808-811. |
||
| 36: | Schüpbach J., Bisset L.R., Regenass S., Bürgisser P., Gorgievski M., Steffen I., Andreutti C., Martinetti G., Shah C., Yerly S., Klimkait T., Gebhardt M., Schöni-Affolter F., Rickenbach M. and the Swiss HIV Cohort Study. | |
| High specificity of line-immunoassay based algorithms for recent HIV-1 infection independent of viral subtype and stage of disease.
BMC Infect. Dis. 2011, 11:254. |
||
| 37: | Scherrer A.U., von Wyl V., Böni J., Yerly S., Klimkait T., Bürgisser P., Garzoni C., Hirschel B., Cavassini M., Battegay M., Vernazza P.L., Bernasconi E., Ledergerber B., Günthard H.F. and the Swiss HIV Cohort Study (SHCS). | |
| Viral suppression rates in salvage treatment with raltegravir improved with the administration of genotypic partially active or inactive nucleoside/tide reverse transcriptase inhibitors.
J. Acquir. Immune Defic. Syndr. 2011, 57:24-31. |
||
| 38: | Scherrer A.U., von Wyl V., Joos B., Klimkait T., Bürgisser P., Yerly S., Böni J., Ledergerber B., Günthard H.F. and the Swiss HIV Cohort Study. | |
| Predictors for the emergence of the 2 multi-nucleoside/nucleotide resistance mutations 69 insertion and Q151M and their impact on clinical outcome in the Swiss HIV cohort study.
J. Infect. Dis. 2011, 203:791-797. |
||
| 39: | Schwab N., Höhn K.G., Schneider-Hohendorf T., Metz I., Stenner M.P., Jilek S., Du Pasquier R.A., Gold R., Meuth S.G., Ransohoff R.M., Brück W. and Wiendl H. | |
| Immunological and clinical consequences of treating a patient with natalizumab.
Mult. Scler. 2011. In press |
||
| 40: | Seebach J.D. and Spertini F. | |
| In process citation.
Rev. Med. Suisse 2011, 7:835-836. |
||
| 41: | Spertini F., Leimgruber A. and Bart P.-A. | |
| What to expect from novel generation of allergy test ?
Rev. Med. Suisse 2011, 7: 856-859. |
||
| 42: | Stadler T., Kouyos R., von Wyl V., Yerly S., Böoni J., Bürgisser P., Klimkait T., Joos B., Rieder P., Xie D., Günthard H.F., Drummond A.J., Bonhoeffer S. and the Swiss HIV Cohort Study. | |
| Estimating the basic reproductive number from viral sequence data.
Mol Biol Evol. 2011. In press. |
||
| 43: | Vallotton L., Hadaya K., Venetz J.-P., Buehler L.H., Ciuffreda D., Nseir G., Codarri L., Villard J., Pantaleo G. and Pascual M. | |
| Monitoring of CD4+CD25highIL-7Rαhigh activated T cells in kidney transplant recipients.
Clin. J. Am. Soc. Nephrol. 2011, 6:2025-2033. |
||
| 44: | Wassenberg J., Nutten S., Audran R., Barbier N., Aubert V., Moulin J., Mercenier A. and Spertini F. | |
| Effect of Lactobacillus paracasei ST11 on a nasal provocation test with grass pollen in allergic rhinitis.
Clin. Exp. Allergy 2011, 41:565-573. |
||
| 45: | von Wyl V., Kouyos R.D., Yerly S., Böni J., Shah C., Bürgisser P., Klimkait T., Weber R., Hirschel B., Cavassini M., Staehelin C., Battegay M., Vernazza P.L., Bernasconi E., Ledergerber B., Bonhoeffer S., Günthard H.F. and the Swiss HIV Cohort Study. | |
| The role of migration and domestic transmission in the spread of HIV-1 non-B subtypes in Switzerland.
J. Infect. Dis. 2011, 204:1095-1103. |
||
Publications : 2010 |
||
| 1: | Alizon S., von Wyl V., Stadler T., Kouyos R.D., Yerly S., Hirschel B., Böni J., Shah C., Klimkait T., Furrer H., Rauch A., Vernazza P.L., Bernasconi E., Battegay M., Bürgisser P., Telenti A., Günthard H.F., Bonhoeffer S. and the Swiss HIV Cohort Study. | |
| Phylogenetic approach reveals that virus genotype largely determines HIV set-point viral load.
PLoS Pathogens 2010, 6:1-9. |
||
| 2: | Aubert C., Vaudaux B. and Bart P.-A. | |
| Immunization guidelines regarding patients with a chronic disease.
Rev. Med. Suisse 2010, 6:798-803. |
||
| 3: | Baltcheva I., Codarri L., Pantaleo G. and Le Boudec J.Y. | |
| Lifelong dynamics of human CD4+CD25+ regulatory T cells: insights from in vivo data and mathematical modeling.
J. Theor. Biol. 2010, 266:307-322. |
||
| 4: | Boyman O., Cho J.H. and Sprent J. | |
| The role of interleukin-2 in memory CD8 cell differentiation.
Adv. Exp. Med. Biol. 2010, 684:28-41. |
||
| 5: | Boyman O. | |
| Bystander activation of CD4+ T cells.
Eur. J. Immunol. 2010, 40:936-939. |
||
| 6: | Castro E., Khonkarly M., Ciuffreda D., Bürgisser P., Cavassini M., Yerly S., Pantaleo G. and Bart P.-A. | |
| HIV-1 drug resistance transmission networks in Southwest Switzerland.
Aids Res. Hum. Retrov. 2010, 26:1233-1238. |
||
| 7: | Cellerai C., Perreau M., Rozot V., Enders F.B., Pantaleo G. and Harari A. | |
| Proliferation capacity and cytotoxic activity are mediated by functionally and phenotypically distinct virus-specific CD8 T cells defined by interleukin-7R{alpha} (CD127) and perforin expression.
J. Virol. 2010, 84:3868-3878. |
||
| 8: | Chappuis S., Vogt P., Petitpierre S., Leimgruber A., Spertini F. and Bart P.-A. | |
| Cardiac involvement in connective tissue disease: the example of systemic lupus erythematosus.
Rev. Med. Suisse 2010, 6:804, 806-811. |
||
| 9: | Ciuffreda D., Codarri L., Buhler L., Vallotton L., Giostra E., Mentha G., Morel P., Pantaleo G. and Pascual M. | |
| Hepatitis C virus infection after liver transplantation is associated with lower levels of activated CD4(+)CD25(+)CD45RO(+)IL-7ralpha(high) T cells.
Liver Transpl. 2010, 16:49-55. |
||
| 10: | Corthésy B. | |
| Role of secretory immunoglobulin A and secretory component in the protection of mucosal surfaces.
Future Microbiol. 2010, 5:817-829. |
||
| 11: | Cvetkovic-Lopes V., Bayer L., Dorsaz S., Maret S., Pradervand S., Dauvilliers Y., Lecendreux M., Lammers G.J., Donjacour C.E., Du Pasquier R.A., Pfister C., Petit B., Hor H., Mühlethaler M. and Tafti M. | |
| Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patients.
J. Clin. Invest. 2010, 120:713-719. |
||
| 12: | Decrausaz L, Revaz V, Bobst M, Corthésy B, Romero P, Nardelli-Haefliger D. | |
| Induction of human papillomavirus oncogene-specific CD8 T-cell effector responses in the genital mucosa of vaccinated mice.
Int. J. Cancer 2010, 126:2469-2478. |
||
| 13: | Du Pasquier R.A. | |
| A promenade along the stream of demyelination.
Curr. Opin. Neurol. 2010., 23:203-204. |
||
| 14: | Duc M., Johansen F.E. and Corthésy B. | |
| Antigen binding to secretory immunoglobulin A results in decreased sensitivity to intestinal proteases and increased binding to cellular Fc receptors.
J. Biol. Chem. 2010, 285:953-960. |
||
| 15: | Duchez S., Amin R., Cogné N., Delpy L., Sirac C., Pascal V., Corthésy B. and Cogné M. | |
| Premature replacement of mu with alpha immunoglobulin chains impairs lymphopoiesis and mucosal homing but promotes plasma cell maturation.
Proc. Natl. Acad. Sci. USA 2010, 107:3064-3069. |
||
| 16: | Dunand M., Botez S.A., Borruat F.X., Roux-Lombard P., Spertini F. and Kuntzer T. | |
| Unsatisfactory outcomes in myasthenia gravis: influence by care providers.
J. Neurol. 2010, 257:338-343. |
||
| 17: | Elzi L., Marzolini C., Furrer H., Ledergerber B., Cavassini M., Hirschel B., Vernazza P., Bernasconi E., Weber R., Battegay M.; Swiss HIV Cohort Study. | |
| Treatment modification in human immunodeficiency virus-infected individuals starting combination antiretroviral therapy between 2005 and 2008.
Arch. Intern. Med. 2010, 170:57-65. |
||
| 18: | Fontana M., Moradpour D., Aubert V., Pantaleo G. and Pascual M. | |
| Prevalence of anti-HLA antibodies after liver transplantation.
Transpl. Int. 2010, 23:858-859. |
||
| 19: | Gambillara E., Spertini F. and Leimgruber A. | |
| Allergic and toxic cutaneous reactions to plants.
Rev. Med. Suisse 2010, 6:824-829. |
||
| 20: | Genton B., D'Acremont V., Lurati-Ruiz F., Verhage D., Audran R., Hermsen C., Wolters L., Reymond C., Spertini F. and Sauerwein R. | |
| Randomized double-blind controlled Phase I/IIa trial to assess the efficacy of malaria vaccine PfCS102 to protect against challenge with P. falciparum.
Vaccine 2010, 28:6573-6580. |
||
| 21: | Gerlach C., van Heijst J.W., Swart E., Sie D., Armstrong N., Kerkhoven R.M., Zehn D., Bevan M.J., Schepers K. and Schumacher T.N. | |
| One naive T cell, multiple fates in CD8+ T cell differentiation.
J. Exp. Med. 2010, 207:1235-1246. |
||
| 22: | Guglietta S., Pantaleo G. and Graziosi C. | |
| Length variation in HIV-1 gp120 as the product of DNA misalignment mechanism.
Retrovirology 2010, 7:21. Suppl.1 |
||
| 23: | Guglietta S., Pantaleo G. and Graziosi C. | |
| Long sequence duplications, repeats and palindromes in HIV-1 gp120: length variation in V4 as the product of misalignment mechanism.
Virology 2010, 399:167-175. |
||
| 24: | Hadaya K., Avila Y., Valloton L., de Rham C., Bandelier C., Ferrari-Lacraz S., Pascual M., Pantaleo G., Martin P.Y., Buhler L. and Villard J. | |
| Natural killer cell receptor-Repertoire and functions after induction therapy by polyclonal rabbit anti-thymocyte globulin in unsensitized kidney transplant recipients.
Clin. Immunol. 2010, 137:250-260. |
||
| 25: | Harari A., Vigano S., Bellutti Enders F., Cellerai C., Castro E., Cavassini M., Bart P.-A. and Pantaleo G. | |
| Modulation of TCR avidity of primary HIV-1-specific CD8 T-cell responses by early and potent antiviral therapy responses.
Aids Res. Hum. Retrov. 2010, 26:A7-A8. |
||
| 26: | Jaquiéry E., Jilek S., Schluep M., Le Goff G., Garcia M., Pantaleo G. and Du Pasquier R.A. | |
| Cytokine mRNA profile of Epstein-Barr virus-stimulated highly differentiated T cells in multiple sclerosis: A pilot study.
J. Neuroimmunol. 2010, 225:167-170. |
||
| 27: | Jaquiéry E., Jilek S., Schluep M., Meylan P., Lysandropoulos A., Pantaleo G. and Du Pasquier R.A. | |
| Intrathecal immune responses to Epstein-Barr virus in early multiple sclerosis.
Eur. J. Immunol. 2010, 40:878-887. |
||
| 28: | Jilek S., Jaquiéry E., Hirsch H.H., Lysandropoulos A., Canales M., Guignard L., Schluep M., Pantaleo G. and Pasquier R.A. | |
| Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal study.
Lancet Neurol. 2010, 9:264-272. |
||
| 29: | Kibler K.V., Perdiguera B., Gomez C.E., Najera J.L., Gonzalez-Sanz R., Jimenez V., Quakkelaar E.D., Melief C.J., Haddad E., Sekaly R., Sallusto F., Lanzavecchia A., Harari A., Huynh T., Holechek S., Tartaglia J., Pantaleo G., Jacobs B.L. and Esteban M. | |
| Improvement of the HIV/AIDS vaccine candidate NYVAC-C by deletion of the viral type I IFN inhibitor and/or acquisition of replication competence.
Aids Res. Hum. Retrov. 2010, 26:A137. |
||
| 30: | Krieg C., Létourneau S., Pantaleo G. and Boyman O. | |
| Improved IL-2 immunotherapy by selective stimulation of IL-2 receptors on lymphocytes and endothelial cells.
Proc. Natl. Acad. Sci. USA 2010, 107:11906-11911. |
||
| 31: | Létourneau S., van Leeuwen E.M., Krieg C., Martin C., Pantaleo G., Sprent J., Surh C.D. and Boyman O. | |
| IL-2/anti-IL-2 antibody complexes show strong biological activity by avoiding interaction with IL-2 receptor alpha subunit CD25.
Proc. Natl. Acad. Sci. USA 2010, 107:2171-2176. |
||
| 32: | Levy Y., Ellefsen K., Stoehr W., Bart P.-A., Lelievre J., Launay O., Wolf H., Weber J., Chene G. and Pantaleo G. | |
| Optimal priming of poxvirus vector (NYVAC)-based HIV vaccine regimens requires 3 DNA injections. Results of the EV03/ANRS Vac20 Phase I/II Trial .
Aids Res. Hum. Retrov. 2010, 26:A10. |
||
| 33: | Lyko C., Bart P.-A., Pruvot E., Prior J. and Waeber G. | |
| Extrapulmonary sarcoidosis: an unrecognized affection ?
Rev. Med. Suisse 2010, 6:2056-2060. |
||
| 34: | Lysandropoulos A.P. and Du Pasquier R.A. | |
| Demyelination as a complication of new immunomodulatory treatments.
Curr. Opin. Neurol. 2010, 23:226-233. |
||
| 35: | Mathias A., Duc M., Favre L., Benyacoub J., Blum S. and Corthésy B. | |
| Potentiation of polarized intestinal Caco-2 cell responsiveness to probiotics complexed with secretory IgA.
J. Biol. Chem. 2010, 285:33906-33913. |
||
| 36: | Mooij P., Nieuwenhuis I., Beenhakker N., Hofman S., Esteban M., Jacobs B., Kibler K., Koopman G., Bogers W., Pantaleo G. and Heeney J. | |
| Improved immunogenicity against HIV-1 clade C antigens by using NYVAC-C with restored replication competence.
Aids Res. Hum. Retrov. 2010, 26:A4-A5. |
||
| 37: | Odman M. and Bart P.-A. | |
| Eosinophilic esophagitis.
Rev. Med. Suisse 2010, 6:1854-1856, 1858. |
||
| 38: | Olugbile S., Habel C., Servis C., Spertini F., Verdini A. and Corradin G. | |
| Malaria vaccines - The long synthetic peptide approach: Technical and conceptual advancements.
Curr. Opin. Mol. Ther. 2010, 12:64-76. |
||
| 39: | Oviedo-Orta E., Perreau M., Evans W.H. and Potolicchio I. | |
| Control of the proliferation of activated CD4+ T cells by connexins.
J. Leukoc. Biol. 2010, 88:79-86. |
||
| 40: | Pantaleo G., Esteban M., Jacobs B. and Tartaglia J. | |
| Poxvirus vector-based HIV vaccines.
Curr. Opin. HIV AIDS 2010, 5:391-396. |
||
| 41: | Perrier C., Thierry A.C., Mercenier A. and Corthésy B. | |
| Allergen-specific antibody and cytokine responses, mast cell reactivity and intestinal permeability upon oral challenge of sensitized and tolerized mice.
Clin. Exp. Allergy 2010, 40:153-162. |
||
| 42: | Rey V., Du Pasquier R., Muehl A., Péter O. and Michel P. | |
| Multiple ischemic strokes due to Borrelia garinii meningovasculitis.
Rev. Neurol. (Paris) 2010, 166:931-934. |
||
| 43: | Seebach J., Bart P.-A. and Spertini F. | |
| Prevention of transmissible diseases.
Rev. Med. Suisse 2010, 6:795-796. |
||
| 44: | Sellner J., Boggild M., Clanet M., Hintzen R.Q., Illes Z., Montalban X., Du Pasquier R.A., Polman C.H., Sorensen P.S. and Hemmer B. | |
| EFNS guidelines on diagnosis and management of neuromyelitis optica.
Eur. J. Neurol. 2010, 17:1019-1032. |
||
| 45: | Simioni S., Cavassini M., Anonni J.-M., Rimbault-Abraham A., Bourquin I., Schiffer V., Calmy A., Chave J.-P., Giacobini E., Hirschel B. and Du Pasquier R.A. | |
| Cognitive dysfunction in HIV patients despite long-standing suppression of viremia.
AIDS 2010, 24:1243-1250. |
||
| 46: | Sizmann D., Glaubitz J., Simon C.O., Goedel S., Buergisser P., Drogan D., Hesse M., Kröh M., Simmler P., Dewald M., Gilsdorf M., Fuerst M., Ineichen R., Kirn A., Pasche P., Wang Z., Weisshaar S., Young K., Haberhausen G. and Babiel R. | |
| Improved HIV-1 RNA quantitation by COBAS((R)) AmpliPrep/COBAS((R)) TaqMan((R)) HIV-1 Test, v2.0 using a novel dual-target approach.
J. Clin. Virol. 2010, 49:41-46. |
||
| 47: | Spertini F., Berney M., Foradini F. and Roulet CA. | |
| Major mite allergen Der f 1 concentration is reduced in buildings with improved energy performance.
Allergy 2010, 65:623-629. |
||
| 48: | Wilks A.B., Christian E.C., Seaman M.S., Sircar P., Carville A., Gomez C.E., Esteban M., Pantaleo G., Barouch D.H., Letvin N.L., and Permar S.R. | |
| Robust vaccine-elicited cellular immune responses in breast milk following systemic Simian Immunodeficiency Virus DNA prime and live virus vector boost vaccination of lactating rhesus monkeys.
J. Immunol. 2010, 185:7097-7106. |
||
| 49: | Zehn D., Turner M.J., Lefrançois L. and Bevan M.J. | |
| Lack of original antigenic sin in recall CD8(+) T cell responses.
J. Immunol. 2010, 184:6320-6326. |
||
| 50: | von Wyl V., Ehteshami M., Demeter L.M., Bürgisser P., Nijhuis M., Symons J., Yerly S., Böni J., Klimkait T., Schuurman R., Ledergerber B., Götte M., Günthard H.F. and Swiss HIV Cohort Study. | |
| HIV-1 reverse transcriptase connection domain mutations: dynamics of emergence and implications for success of combination antiretroviral therapy.
Clin. Infect. Dis. 2010, 51:620-628. |
||
Publications : 2009 |
||
| 1: | Aubert V., Venetz J.-P., Pantaleo G. and Pascual M. | |
| Are all donor-specific antibodies detected by solid-phase assay before transplantation clinically relevant ?
Transplantation 2009, 87:1897-1898. |
||
| 2: | Aubert V., Venetz J.-P., Pantaleo G. and Pascual M. | |
| Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant.
Hum. Immunol. 2009, 70:580-583. |
||
| 3: | Audran R., Lurati-Ruiz F., Genton B., Blythman H.E., Ofori-Anyinam O., Reymond C., Corradin G. and Spertini F. | |
| The synthetic Plasmodium falciparum circumsporozoite peptide PfCS102 as a malaria vaccine candidate: a randomized controlled phase I trial.
PLoS One 2009, 4:e7304. |
||
| 4: | Bélair M., Dovat M., Foley B., Mayerat C., Pantaleo G. and Graziosi C. | |
| The polymorphic nature of HIV type 1 env V4 affects the patterns of potential N-glycosylation sites in proviral DNA at the intrahost level.
AIDS Res. Hum. Retroviruses 2009, 25:199-206. |
||
| 5: | Boudousquié C., Pellaton C., Barbier N. and Spertini F. | |
| CD4+CD25+ T cell depletion impairs tolerance induction in a murine model of asthma.
Clin. Exp. Allergy 2009, 39:1415-1426. |
||
| 6: | Boullier S., Tanguy M., Kadaoui K.A., Caubet C., Sansonetti P., Corthésy B. and Phalipon A. | |
| Secretory IgA-mediated neutralization of Shigella flexneri prevents intestinal tissue destruction by down-regulating inflammatory circuits.
J. Immunol. 2009, 183:5879-5885. |
||
| 7: | Boyman O., Létourneau S., Krieg C. and Sprent J. | |
| Homeostatic proliferation and survival of naïve and memory T cells.
Eur. J. Immunol. 2009, 39:2088-2094. |
||
| 8: | Bunbury A., Potolicchio I., Maitra R. and Santambrogio L. | |
| Functional analysis of monocyte MHC class II compartments.
FASEB J. 2009, 23:164-171. |
||
| 9: | Castillo J., Comegna M., Quijada W., Jauvin V., Pinson P., Masquelier B., Fleury H. and Castro E. | |
| Surveillance of HIV-1 drug resistance among naive patients from Venezuela.
AIDS Res. Hum. Retroviruses 2009, 25:1329-1333. |
||
| 10: | Cellerai C., Perreau M., Rozot V., Bellutti Enders F., Bart P.-A., Pantaleo G. and Harari A. | |
| Antigen exposure regulates the balance between proliferating and cytotoxic subsets of virus-specific CD8 T-cells
Retrovirology 2009, 6(Suppl 3):261. |
||
| 11: | Chakour R., Leimgruber A., Bart P.-A. and Spertini F. | |
| Therapeutic strategies in idiopatic inflammatory myopathies.
Rev. Med. Suisse 2009, 5:812-818. |
||
| 12: | Clerc O., Cavassini M., Böni J., Schüpbach J. and Bürgisser P. | |
| Prolonged seroconversion in an elite controller of HIV-1 infection.
J. Clin. Virol. 2009, 46:371-373. |
||
| 13: | Comte-Perret S., Bart P.-A., Spertini F. and Leimgruber A. | |
| Mastocytosis: when should it be considered ?
Rev. Med. Suisse 2009, 5:837-842. |
||
| 14: | Corthésy B. | |
| Secretory immunoglobulin A: well beyond immune exclusion at mucosal surfaces.
Immunopharmacol. Immunotoxicol. 2009, 31:174-179. |
||
| 15: | Delaloye J., Roger T., Steiner-Tardivel Q.G., Le Roy D., Knaup Reymond M., Akira S., Petrilli V., Gomez C.E., Perdiguero B., Tschopp J., Pantaleo G., Esteban M. and Calandra T. | |
| Innate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasome.
PLoS Pathog. 2009, 5:e1000480. |
||
| 16: | Du Pasquier R., Cavassini M., Simioni S., Annoni J.M., Giacobini E. and Hirschel B. | |
| New spectrum of HIV-associated cognitive disorders in the HAART era.
Rev. Med. Suisse 2009, 5:955-956, 958-961. |
||
| 17: | Harari A., Bellutti Enders F., Cellerai C., Bart P.-A. and Pantaleo G. | |
| Distinct profiles of cytotoxic granules in memory CD8 T-cells correlate with function, differentiation stage and antigen exposure.
J. Virol. 2009, 83:2862-2871. |
||
| 18: | Jaquiéry E. , Jilek S. , Schluep M. , Meylan P. , Lysandropoulos A. , Pantaleo G. and Du Pasquier R.A. | |
| Increased EBV reactivation in the cerebrospinal fluid of patients with early multiple sclerosis.
J. Neurovirol. 2009, 15:38. |
||
| 19: | Jilek Terrasse S. , Lysandropoulos A. , Jaquiéry E. , Canales M. , Guignard L. , Campiche C. , Schluep M. , Pantaleo G. and Du Pasquier R.A. | |
| Viral- and myelin-specific cellular immune response in patients treated with natalizumab: a cross-sectional and a longitudinal prospective study.
J. Neurovirol. 2009, 15 (Suppl. 1):39-40. |
||
| 20: | Khanna N., Wolbers M., Mueller N.J., Garzoni C., Du Pasquier R.A., Fux C.A., Vernazza P., Bernasconi E., Viscidi R., Battegay M. and Hirsch H.H.; Swiss HIV Cohort Study. | |
| JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy.
J. Virol. 2009, 83:4404-4411. |
||
| 21: | Krieg C. and Boyman O. | |
| The role of chemokines in cancer immune surveillance by the adaptive immune system.
Semin. Cancer Biol. 2009, 19:76-83. |
||
| 22: | Létourneau S., Krieg C., Pantaleo G. and Boyman O. | |
| IL-2- and CD25-dependent immunoregulatory mechanisms in the homeostasis of T-cell subsets.
J. Allergy Clin. Immunol. 2009, 123:758-762. |
||
| 23: | Lê Huu S., Spertini F., Roggero P., Egloff D.V. and Raffoul W. | |
| Pyoderma gangrenosum: a rare pathology or an omitted diagnosis ?
Ann. Chir. Plast. Esthet. 2009, 54:82-87. |
||
| 24: | Lalive P.H., Chofflon M., Du Pasquier R.A. and Burkhard P.R. | |
| Autoantibodies in neurological diseases: clinical implications
Rev. Med. Suisse 2009, 5:942-944, 946-948, 950. |
||
| 25: | Leimgruber A. and Spertini F. | |
| Allergie rhinoconjunctivitis and immunotherapy: an uptodate.
Rev. Med. Suisse 2009, 14:88-93. |
||
| 26: | Mooij P., Balla-Jhagjhoorsingh S.S., Beenhakker N., van Haaften P., Baak I., Nieuwenhuis I.G., Heidari S., Wolf H., Frachette M.J., Bieler K., Sheppard N., Harari A., Bart P.-A., Liljeström P., Wagner R., Pantaleo G. and Heeney JL. | |
| Comparison of human and rhesus macaque T-cell responses elicited by boosting with NYVAC encoding HIV-1 clade C immunogens.
J. Virol. 2009, 83:5881-5889. |
||
| 27: | Novy J., Carota A., Eggiman D., Pusztaszeri M., Rossetti A.O. and Du Pasquier R.A. | |
| Encephalitis, HSV-2 in the cerebrospinal fluid and anti-RI (ANNA-2) antibodies: an infectious or a paraneoplastic syndrome ?
BMJ Case Reports. August 11, 2009. |
||
| 28: | Olugbile S., Kulangara C., Bang G., Bertholet S., Suzarte E., Villard V., Frank G., Audran R., Razaname A., Nebie I., Awobusuyi O., Spertini F., Kajava A.V., Felger I., Druilhe P. and Corradin G. | |
| Vaccine potentials of an intrinsically unstructured fragment derived from the blood stage-associated Plasmodium falciparum protein PFF0165c.
Infect. Immun. 2009, 77:5701-5709. |
||
| 29: | Perrier C., Thierry A.C., Mercenier A. and Corthésy B. | |
| Allergen-specific antibody and cytokine responses, mast cell reactivity and intestinal permeability upon oral challenge of sensitized and tolerized mice.
Clin. Exp. Allergy 2009, 40:153-162. |
||
| 30: | Petitpierre S., Aubert V., Leimgruber A., Spertini F. and Bart P.-A. | |
| Use of autoantibodies in clinical practice.
Rev. Med. Suisse 2009, 5:823-831. |
||
| 31: | Rosselet A., Vu D.H., Meylan P., Chaubert A.S., Schapira M., Pascual M., Aubert V., Tissot J.D. and Duchosal M.A. | |
| Associations of serum EBV DNA and gammopathy with post-transplant lymphoproliferative disease.
Clin. Transplant. 2009, 23:74-82. |
||
| 32: | Scherrer A.U., Hasse B., von Wyl V., Yerly S., Böni J., Bürgisser P., Klimkait T., Bucher H.C., Ledergerber B. and Günthard H.F. | |
| Prevalence of etravirine mutations and impact on response to treatment in routine clinical care: the Swiss HIV Cohort Study (SHCS).
HIV Med. 2009, 10:647-656. |
||
| 33: | Schmutz S., Bosco N., Chappaz S., Boyman O., Acha-Orbea H., Ceredig R., Rolink A.G. and Finke D. | |
| Cutting edge: IL-7 regulates the peripheral pool of adult ROR gamma+ lymphoid tissue inducer cells.
J. Immunol. 2009, 183:2217-2221. |
||
| 34: | Simioni S., Ruffieux C., Kleeberg J., Bruggimann L., du Pasquier R.A., Annoni J.M. and Schluep M. | |
| Progressive decline of decision-making performances during multiple sclerosis.
J. Int. Neuropsychol. Soc. 2009, 15:291-295. |
||
| 35: | Spertini F. and Seebach J. | |
| Allergology and clinical immunology: a crossover discipline.
Rev. Med. Suisse 2009, 5:803-804. |
||
| 36: | Taegtmeyer A.B., Steurer-Stey C., Price D.B., Wildhaber J.H., Spertini F. and Leuppi JD. | |
| Predictors of asthma control in everyday clinical practice in Switzerland.
Curr. Med. Res. Opin. 2009, 25:2549-2555. |
||
| 37: | Taegtmeyer A.B., Steurer-Stey C., Spertini F., Bircher A., Helbling A., Miedinger D., Schafroth S., Scherer K. and Leuppi J.D. | |
| Allergic rhinitis in patients with asthma: the Swiss LARA (Link Allergic Rhinitis in Asthma) survey.
Curr. Med. Res. Opin. 2009, 25:1073-1080. |
||
| 38: | Thierry A.C., Bernasconi E., Mercenier A. and Corthésy B. | |
| Conditioned polarized Caco-2 cell monolayers allow to discriminate for the ability of gut-derived microorganisms to modulate permeability and antigen-induced basophil degranulation.
Clin. Exp. Allergy 2009, 39:527-536. |
||
| 39: | Webster K.E., Walters S., Kohler R.E., Mrkvan T., Boyman O., Surh C.D., Grey S.T. and Sprent J. | |
| In vivo expansion of T reg cells with IL-2-mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression.
J. Exp. Med. 2009, 206:751-760. |
||
| 40: | Wild J., Bieler K., Köstler J., Frachette M.J., Jeffs S., Vieira S., Esteban M., Liljeström P., Pantaleo G., Wolf H. and Wagner R. | |
| Preclinical evaluation of the immunogenicity of C-type HIV-1-based DNA and NYVAC vaccines in the Balb/C mouse model.
Viral Immunol. 2009, 22:309-319. |
||
Publications : 2008 |
||
| 1: | Aubert V., Graf Pisler I. and Spertini F. | |
| Improved diagnoses of autoimmune hepatitis using an anti-actin ELISA.
J. Clin. Lab. Anal. 2008, 22:340-345. |
||
| 2: | Bandelier C., Leimgruber A., Wassenberg J., Bart P.-A. and Spertini F. | |
| Rare food allergies.
Rev. Med. Suisse 2008, 4:1024-1026, 1028-1029. |
||
| 3: | Bart P.-A., Goodall R., Barber T., Harari A., Guimaraes-Walker A., Khonkarly M., Sheppard N.C., Bangala Y., Frachette M.J., Wagner R., Liljeström P., Kraehenbuhl J.-P., Girard M., Goudsmit J., Esteban M., Heeney J., Sattentau Q., McCormack S., Babiker A., Pantaleo G. and Weber J.; EuroVacc Consortium. | |
| EV01: A phase I trial in healthy HIV negative volunteers to evaluate a clade C HIV vaccine, NYVAC-C undertaken by the EuroVacc Consortium.
Vaccine 2008, 26:3153-3161. |
||
| 4: | Bart P.-A. | |
| When should consider antiphospholipid syndrome ?
Rev. Med. Suisse 2008, 4:97-99. |
||
| 5: | Berguiga M., Abouzeid H., Bart P.-A. and Guex-Crosier Y. | |
| Severe occlusive vasculitis as a complication of cat scratch disease1.
Klin. Monatsbl. Augenheilkd. 2008, 225:486-487. |
||
| 6: | Betts M.R. and Harari A. | |
| Phenotype and function of protective T cell immune rsponses in HIV.
Curr. Opin. HIV AIDS 2008, 3:349-355. |
||
| 7: | Boyman O., Ramsey C., Kim D.M., Sprent J. and Surh C.D. | |
| IL-7/anti-IL-7 mAb complexes restore T cell development and induce homeostatic T Cell expansion without lymphopenia.
J. Immunol. 2008, 180:7265-7275. |
||
| 8: | Brembilla N.C., Weber J., Rimoldi D., Pradervand S., Schutz F., Pantaleo G., Ruegg C., Quadroni M., Harshman K. and Doucey M.-A. | |
| c-Cbl expression levels regulate the functional responses of human central and effector memory CD4 T cells.
Blood 2008, 112:652-660. |
||
| 9: | Burkhard P.R., Vingerhoets F.J., Landis T. and Du Pasquier R.A. | |
| Neuropsychiatry.
Rev. Med. Suisse 2008, 4:1131-1132. |
||
| 10: | Burton C.T., Goodall R.L., Samri A., Autran B., Kelleher A.D., Poli G., Pantaleo G., Gotch F.M., Imami N.; INITIO Trial International Co-ordinating Committee. | |
| Restoration of anti-tetanus toxoid responses in patients initiating highly active antiretroviral therapy with or without a boost immunization: an INITIO substudy.
Clin. Exp. Immunol. 2008, 152:252-257. |
||
| 11: | Castro E., Bélair M., Rizzardi G.P., Bart P.-A., Pantaleo G. and Graziosi C. | |
| Independent evolution of hypervariable regions of HIV-1 gp120: V4 as a swarm of N-Linked glycosylation variants.
AIDS Res. Hum. Retroviruses 2008, 24:106 -113. |
||
| 12: | Cereda C. and Du Pasquier R. | |
| Neurology.
Rev. Med. Suisse 2008, 9;4:49-50, 52-56. |
||
| 13: | Ciuffreda D., Comte D., Cavassini M., Giostra E., Bühler L., Perruchoud M., Heim M.H., Battegay M., Genné D., Mulhaupt B., Malinverni R., Oneta C., Bernasconi E., Monnat M., Cerny A., Chuard C., Borovicka J., Mentha G., Pascual M., Gonvers J.J., Pantaleo G. and Dutoit V. | |
| Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication.
Eur. J. Immunol. 2008, 38:2665-2677. |
||
| 14: | Corbett M., Bogers W.M., Heeney J.L., Gerber S., Genin C., Didierlaurent A., Oostermeijer H., Dubbes R., Braskamp G., Lerondel S., Gomez C.E., Esteban M., Wagner R., Kondova I., Mooij P., Balla-Jhagjhoorsingh S., Beenhakker N., Koopman G., van der Burg S., Kraehenbuhl J.-P. and Le Pape A. | |
| Aerosol immunization with NYVAC and MVA vectored vaccines is safe, simple, and immunogenic.
Proc. Natl. Acad. Sci. USA 2008, 105:2046-2051. |
||
| 15: | Ehrhard S., Wernli M., Kaufmann G., Pantaleo G., Rizzardi G.P., Gudat F., Erb P. and Battegay M. | |
| Effect of antiretroviral therapy on apoptosis markers and morphology in peripheral lymph nodes of HIV-infected Individuals.
Infection 2008, 36:120-129. |
||
| 16: | Gaucher D., Therrien R., Kettaf N., Angermann B.R., Boucher G., Filali-Mouhim A., Moser J.M., Mehta R.S., Drake III D.R., Castro E., Akondy R., Rinfret A., Yassine-Diab B., Said E.A., Chouikh Y., Cameron M.J., Clum R., Kelvin D., Somogyi R., Greller L.D., Balderas R.S., Wilkinson P., Pantaleo G., Tartaglia J., Haddad E.K. and Sékaly R.-P. | |
| Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses.
J. Exp. Med. 2008, 205:3119-3131. |
||
| 17: | Harari A. and Pantaleo G. | |
| HIV-1-specific immune response.
Adv. Pharmacol. 2008, 56:75-92. |
||
| 18: | Harari A., Bart P.-A., Stöhr W., Tapia G., Garcia M., Medjitna-Rais E., Burnet S., Cellerai C., Erlwein O., Barber T., Moog C., Liljestrom P., Wagner R., Wolf H., Kraehenbuhl J.-P., Esteban M., Heeney J., Frachette M.J., Tartaglia J., McCormack S., Babiker A., Weber J. and Pantaleo G. | |
| An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses.
J. Exp. Med. 2008, 205:63-77. |
||
| 19: | Harari A., Bellutti Enders F., Garcia M. and Pantaleo G. | |
| Insight in the factors associated with the presence of protective antiviral T-cell response.
Cytometry B. Clin. Cytom. 2008, 1:47. |
||
| 20: | Jilek S., Schluep M., Meylan P., Vingerhoets F., Guignard L., Monney A., Kleeberg J., Le Goff G., Pantaleo G. and Du Pasquier R.A. | |
| Strong EBV-specific CD8+ T cell response in patients with early multiple sclerosis.
Brain 2008, 131:1712-1721. |
||
| 21: | Kleeberg J., Maire R., Chave J.-P., Pournaras J.-A., Guex-Crosier Y. and Du Pasquier R.A. | |
| Inaugural description of Cogan syndrome in an HIV-infected person.
J. Neurol. 2008, 255:1427-1428. |
||
| 22: | Leimgruber A. | |
| Allergic reactions to nonsteroidal anti-inflammatory drugs.
Rev. Med. Suisse 2008, 4:100-103. |
||
| 23: | McCormack S., Stöhr W., Barber T., Bart P.-A., Harari A., Moog C., Ciuffreda D., Cellerai C., Cowen M., Gamboni R., Burnet S., Legg K., Brodnicki E., Wolf H., Wagner R., Heeney J., Frachette M.J., Tartaglia J., Babiker A., Pantaleo G. and Weber J. | |
| EV02: A Phase I trial to compare the safety and immunogenicity of HIV DNA-C prime-NYVAC-C boost to NYVAC-C alone.
Vaccine 2008, 26:3162-3174. |
||
| 24: | Miconnet I. and Pantaleo G. | |
| A soluble hexameric form of CD40 ligand activates human dendritic cells and augments memory T cell response.
Vaccine 2008, 26:4006-4014. |
||
| 25: | Muhlbacher A., Weber B., Burgisser P., Eiras A., Cabrera J., Louisirirotchanakul S., Tiller F.W., Kim H.S., Helden J.V., Bossi V. and Echevarria J.M. | |
| Multicenter study of a new fully automated HBsAg screening assay with enhanced sensitivity for the detection of HBV mutants.
Med. Microbiol. Immunol. 2008, 197:55-64. |
||
| 26: | Pantaleo G. | |
| HIV-1 T-cell vaccines: evaluating the next step.
Lancet Infect. Dis. 2008, 8:82-83. |
||
| 27: | Perreau M., Pantaleo G. and Kremer E.J. | |
| Activation of a dendritic cell–T cell axis by Ad5 immune complexes creates an improved environment for replication of HIV in T cells.
J. Exp. Med. 2008, 205:2717-2725. |
||
| 28: | Petitpierre S., Bart P.-A., Spertini F. and Leimgruber A. | |
| The multiple etiologies of angioedema
Rev. Med. Suisse 2008, 4:1030-1034, 1036-1038. |
||
| 29: | Petropoulos I.K., Zuber J.-P. and Guex-Crosier Y. | |
| Heerfordt syndrome with unilateral facial nerve palsy: a rare presentation of sarcoidosis.
Klin. Monatsbl. Augenheilkd. 2008, 225:453-456. |
||
| 30: | Sprent J., Cho J.H., Boyman O. and Surh C.D. | |
| T cell homeostasis.
Immunol. Cell. Biol. 2008, 86:312-319. |
||
| 31: | Thierrin L., Steiger D., Zuber J.-P., Spertini F., Brunisholz Y. and Delaloye J.-F. | |
| Severe anaphylactic shock to Patent Blue V with cardiac arrest during breast carcinoma surgery with lymphatic mapping.
Eur. J. Obstet. Gynecol. Reprod. Biol. 2008, 140:140-141. |
||
| 32: | Villard J. and Spertini F. | |
| The eternal gap...
Rev. Med. Suisse 2008, 4:1011. |
||
| 33: | Weiser B., Philpott S., Klimkait T., Burger H., Kitchen C., Bürgisser P., Gorgievski M., Perrin L., Piffaretti J.C. and Ledergerber B.; Swiss HIV Cohort Study. | |
| HIV-1 coreceptor usage and CXCR4-specific viral load predict clinical disease progression during combination antiretroviral therapy.
AIDS 2008, 22:469-479. |
||
| 34: | Zuber J.-P., Bart P.-A., Leimgruber A. and Spertini F. | |
| Behçet's disease: from hippocrates to TNF-alpha-blockers.
|
||
|
|